• Anticoagulants. These medications decrease the blood’s ability to clot. They are used in patients who experience symptoms to prevent clots from enlarging or to stop new clots from forming. They do not break up existing clots. Depending on the severity of the DVT, anticoagulant therapy may begin immediately after diagnosis and continue for several months (usually 3 to 6 months). If the patient has other conditions that may contribute to the DVT (e.g. cancer), anticoagulant therapy will often last as long as those other conditions are present. Anticoagulant medications may be administered in the hospital (e.g., heparin), followed by an oral prescription (e.g., warfarin). It is very important to closely monitor anticoagulant medications, using the international normalized ratio (INR), closely while they are being used to reduce the risk of bleeding. Newer forms of heparin have been studied that allow for safe treatment of DVT without hospitalization.

  • Clot-busting drugs (thrombolytics). These medications dissolve existing blood clots. They are frequently used among stroke patients to rapidly dissolve blood clots that occur in the brain. However, in DVT their use is somewhat controversial, since anticoagulant therapy is effective and thrombolytics are connected to increased bleeding and many DVT patients also recently had surgery, which would prohibit the use of clot-busting drugs. Their use is usually reserved for severely symptomatic blood clots that are life-threatening.

  • Thrombin inhibitors. These are newer medications that interfere with the blood’s clotting process. They are often used with patients who cannot tolerate anticoagulation.